Report Cover

Rare Disease Treatment Market Size By Drug Type (Biologics, Non-biologics), By Therapeutic Area (Cancer, Blood-related Disorders, Central Nervous System (CNS), Respiratory Disorders, Musculoskeletal Disorders, Cardiovascular Disorders), By Patient (Adult, Pediatric), By Route of Administration (Oral, Injectable), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2020 - 2026


It is estimated that global rare disease treatment market size will witness an exponential growth in the near future, with an increasing occurrence of numerous rare disorders worldwide and the need for efficient diagnostic and treatment solutions. Different regions and countries have different definitions of a rare disease. In the U.S., a disease is called a rare disease if it affects less than 200,000 individuals. Whereas in the European Union, a rare disease is defined as a condition which affects less than 1 in 2,000 individuals. 

Based on the type of drug, global rare disease treatment industry is bifurcated into biologic and non-biologic. The non-biologic drugs segment accounted for a revenue share of more than US$20,185 million in 2019 and is estimated to record a robust 20.5% CAGR through 2026. Their widespread adoption can be associated with the immunogenicity provided by non-biologic drugs. 

On the basis of therapeutic area, the market is segmented into cardiovascular diseases, respiratory disorders, blood-related disorders, musculoskeletal disorders, and cancers. Global rare disease treatment market size from cardiovascular disorders surpassed US$5,598 million in 2019 and is anticipated to register a CAGR of more than 10.5% through 2026. 

The past several years have witnessed a massive upsurge in the prevalence of rare cardiovascular diseases, such as Brugada syndrome, across both emerging and developed countries. Consequently, these countries are investing in research and experimentation for development of safe and effective therapeutic treatments. 

In terms of the patient age, global rare disease treatment industry is classified into adults and pediatric. The adults segment exceeded an annual valuation of over US$115,183 million in 2019 and is likely to grow at a CAGR of nearly 12.1% through 2026. This can be attributed to a higher risk and prevalence of several rare diseases among adults. 

Although rare diseases my differ from common diseases in terms of aetiology and symptoms, many of these diseases are chronic, require complex care, have no effective treatment, and involve multi-system dysfunction. As a result, these diseases present numerous challenges to health-related quality of life, especially among adults with busy lifestyles. 

Depending upon the route administration, the market segmented into oral and injectable drugs. The injectable segment was valued at US$63,981 million in 2019 and is projected to exhibit a healthy CAGR of over 16.1% up to 2026. Injectables are widely preferred for treatment of numerous conditions due to immediate and effective treatment. 

From a geographical standpoint, the rare disease treatment market in Middle East and Africa was estimated to be worth US$4,443 million in 2019 and is likely to register a CAGR of approximately 12.7% through 2026. The regional growth can be mainly associated with increasing government investments in the healthcare sector. With a growing burden of several diseases, the region is focusing on development of its healthcare infrastructure in order to provide effective treatment and enhanced patient care.
Report Content
Chapter 1   Methodology
1.1    Market definitions
1.2    Base estimates & working
1.3    Forecast calculations
1.4    Data validation
1.5    Data sources
1.5.1    Secondary
1.5.1.1    Paid sources
1.5.1.2    Unpaid sources
1.5.2    Primary
Chapter 2   Executive Summary
2.1    Rare disease treatment industry 360 degree synopsis, 2015 - 2026 (USD Million)
2.1.1    Business trends
2.1.2    Drug type trends
2.1.3    Therapeutic area trends
2.1.4    Patient trends
2.1.5    Route of administration trends
2.1.6    Regional trends
Chapter 3   Rare Disease Treatment Industry Insights
3.1    Industry segmentation
3.2    Industry landscape, 2015 - 2026 (USD Million)
3.3    Industry impact factors
3.3.1    Growth drivers
3.3.1.1    Increase in number of rare disease cases across the globe
3.3.1.2    Favourable government policies
3.3.1.3    Growing number of new drug launches
3.3.1.4    Increasing R&D activities for novel therapeutics and drugs
3.3.2    Industry pitfalls & challenges
3.3.2.1    Lack of awareness regarding rare disease treatment
3.3.2.2    High cost of the drugs and therapy
3.4    Growth potential analysis
3.4.1    By drug type
3.4.2    By therapeutic area
3.4.3    By patient
3.4.4    By route of administration
3.5    COVID-19 impact analysis
3.6    Regulatory landscape
3.6.1    U.S.
3.6.2    Europe
3.6.3    Asia Pacific
3.7    Porter's analysis
3.8    Competitive landscape, 2019
3.8.1    Competitive matrix analysis
3.9    PESTEL analysis
Chapter 4   Rare Disease Treatment Market, By Drug Type
4.1    Key segment trends
4.2    Biologics
4.2.1    Market size, by region, 2015 - 2026 (USD Million)
4.3    Non-biologics
4.3.1    Market size, by region, 2015 - 2026 (USD Million)
Chapter 5   Rare Disease Treatment Market, By Therapeutic Area
5.1    Key segment trends
5.2    Cancer
5.2.1    Market size, by region, 2015 - 2026 (USD Million)
5.3    Blood-related Disorders
5.3.1    Market size, by region, 2015 - 2026 (USD Million)
5.4    Central Nervous System (CNS)
5.4.1    Market size, by region, 2015 - 2026 (USD Million)
5.5    Respiratory Disorders
5.5.1    Market size, by region, 2015 - 2026 (USD Million)
5.6    Musculoskeletal Disorders
5.6.1    Market size, by region, 2015 - 2026 (USD Million)
5.7    Cardiovascular Disorders
5.7.1    Market size, by region, 2015 - 2026 (USD Million)
5.8    Others
5.8.1    Market size, by region, 2015 - 2026 (USD Million)
Chapter 6   Rare Disease Treatment Market, By Patient
6.1    Key segment trends
6.2    Adult
6.2.1    Market size, by region, 2015 - 2026 (USD Million)
6.3    Pediatric
6.3.1    Market size, by region, 2015 - 2026 (USD Million)
Chapter 7   Rare Disease Treatment Market, By Route of Administration
7.1    Key segment trends
7.2    Oral
7.2.1    Market size, by region, 2015 - 2026 (USD Million)
7.3    Injectable
7.3.1    Market size, by region, 2015 - 2026 (USD Million)
Chapter 8   Rare Disease Treatment Market, By Region
8.1    Key segment trends
8.2    North America
8.2.1    Market size, by country, 2015 - 2026 (USD Million)
8.2.2    Market size, by drug type, 2015 - 2026 (USD Million)
8.2.3    Market size, by therapeutic area, 2015 - 2026 (USD Million)
8.2.4    Market size, by patient, 2015 - 2026 (USD Million)
8.2.5    Market size, by route of administration, 2015 - 2026 (USD Million)
8.2.6    U.S.
8.2.6.1    Market size, by drug type, 2015 - 2026 (USD Million)
8.2.6.2    Market size, by therapeutic area, 2015 - 2026 (USD Million)
8.2.6.3    Market size, by patient, 2015 - 2026 (USD Million)
8.2.6.4    Market size, by route of administration, 2015 - 2026 (USD Million)
8.2.7    Canada
8.2.7.1    Market size, by drug type, 2015 - 2026 (USD Million)
8.2.7.2    Market size, by therapeutic area, 2015 - 2026 (USD Million)
8.2.7.3    Market size, by patient, 2015 - 2026 (USD Million)
8.2.7.4    Market size, by route of administration, 2015 - 2026 (USD Million)
8.3    Europe
8.3.1    Market size, by country, 2015 - 2026 (USD Million)
8.3.2    Market size, by drug type, 2015 - 2026 (USD Million)
8.3.3    Market size, by therapeutic area, 2015 - 2026 (USD Million)
8.3.4    Market size, by patient, 2015 - 2026 (USD Million)
8.3.5    Market size, by route of administration, 2015 - 2026 (USD Million)
8.3.6    Germany
8.3.6.1    Market size, by drug type, 2015 - 2026 (USD Million)
8.3.6.2    Market size, by therapeutic area, 2015 - 2026 (USD Million)
8.3.6.3    Market size, by patient, 2015 - 2026 (USD Million)
8.3.6.4    Market size, by route of administration, 2015 - 2026 (USD Million)
8.3.7    UK
8.3.7.1    Market size, by drug type, 2015 - 2026 (USD Million)
8.3.7.2    Market size, by therapeutic area, 2015 - 2026 (USD Million)
8.3.7.3    Market size, by patient, 2015 - 2026 (USD Million)
8.3.7.4    Market size, by route of administration, 2015 - 2026 (USD Million)
8.3.8    France
8.3.8.1    Market size, by drug type, 2015 - 2026 (USD Million)
8.3.8.2    Market size, by therapeutic area, 2015 - 2026 (USD Million)
8.3.8.3    Market size, by patient, 2015 - 2026 (USD Million)
8.3.8.4    Market size, by route of administration, 2015 - 2026 (USD Million)
8.3.9    Spain
8.3.9.1    Market size, by drug type, 2015 - 2026 (USD Million)
8.3.9.2    Market size, by therapeutic area, 2015 - 2026 (USD Million)
8.3.9.3    Market size, by patient, 2015 - 2026 (USD Million)
8.3.9.4    Market size, by route of administration, 2015 - 2026 (USD Million)
8.3.10    Italy
8.3.10.1    Market size, by drug type, 2015 - 2026 (USD Million)
8.3.10.2    Market size, by therapeutic area, 2015 - 2026 (USD Million)
8.3.10.3    Market size, by patient, 2015 - 2026 (USD Million)
8.3.10.4    Market size, by route of administration, 2015 - 2026 (USD Million)
8.4    Asia Pacific
8.4.1    Market size, by country, 2015 - 2026 (USD Million)
8.4.2    Market size, by drug type, 2015 - 2026 (USD Million)
8.4.3    Market size, by therapeutic area, 2015 - 2026 (USD Million)
8.4.4    Market size, by patient, 2015 - 2026 (USD Million)
8.4.5    Market size, by route of administration, 2015 - 2026 (USD Million)
8.4.6    China
8.4.6.1    Market size, by drug type, 2015 - 2026 (USD Million)
8.4.6.2    Market size, by therapeutic area, 2015 - 2026 (USD Million)
8.4.6.3    Market size, by patient, 2015 - 2026 (USD Million)
8.4.6.4    Market size, by route of administration, 2015 - 2026 (USD Million)
8.4.7    Japan
8.4.7.1    Market size, by drug type, 2015 - 2026 (USD Million)
8.4.7.2    Market size, by therapeutic area, 2015 - 2026 (USD Million)
8.4.7.3    Market size, by patient, 2015 - 2026 (USD Million)
8.4.7.4    Market size, by route of administration, 2015 - 2026 (USD Million)
8.4.8    India
8.4.8.1    Market size, by drug type, 2015 - 2026 (USD Million)
8.4.8.2    Market size, by therapeutic area, 2015 - 2026 (USD Million)
8.4.8.3    Market size, by patient, 2015 - 2026 (USD Million)
8.4.8.4    Market size, by route of administration, 2015 - 2026 (USD Million)
8.4.9    Australia
8.4.9.1    Market size, by drug type, 2015 - 2026 (USD Million)
8.4.9.2    Market size, by therapeutic area, 2015 - 2026 (USD Million)
8.4.9.3    Market size, by patient, 2015 - 2026 (USD Million)
8.4.9.4    Market size, by route of administration, 2015 - 2026 (USD Million)
8.4.10    South Korea
8.4.10.1    Market size, by drug type, 2015 - 2026 (USD Million)
8.4.10.2    Market size, by therapeutic area, 2015 - 2026 (USD Million)
8.4.10.3    Market size, by patient, 2015 - 2026 (USD Million)
8.4.10.4    Market size, by route of administration, 2015 - 2026 (USD Million)
8.5    Latin America
8.5.1    Market size, by country, 2015 - 2026 (USD Million)
8.5.2    Market size, by drug type, 2015 - 2026 (USD Million)
8.5.3    Market size, by therapeutic area, 2015 - 2026 (USD Million)
8.5.4    Market size, by patient, 2015 - 2026 (USD Million)
8.5.5    Market size, by route of administration, 2015 - 2026 (USD Million)
8.5.6    Brazil
8.5.6.1    Market size, by drug type, 2015 - 2026 (USD Million)
8.5.6.2    Market size, by therapeutic area, 2015 - 2026 (USD Million)
8.5.6.3    Market size, by patient, 2015 - 2026 (USD Million)
8.5.6.4    Market size, by route of administration, 2015 - 2026 (USD Million)
8.5.7    Mexico
8.5.7.1    Market size, by drug type, 2015 - 2026 (USD Million)
8.5.7.2    Market size, by therapeutic area, 2015 - 2026 (USD Million)
8.5.7.3    Market size, by patient, 2015 - 2026 (USD Million)
8.5.7.4    Market size, by route of administration, 2015 - 2026 (USD Million)
8.5.8    Argentina
8.5.8.1    Market size, by drug type, 2015 - 2026 (USD Million)
8.5.8.2    Market size, by therapeutic area, 2015 - 2026 (USD Million)
8.5.8.3    Market size, by patient, 2015 - 2026 (USD Million)
8.5.8.4    Market size, by route of administration, 2015 - 2026 (USD Million)
8.6    Middle East and Africa
8.6.1    Market size, by country, 2015 - 2026 (USD Million)
8.6.2    Market size, by drug type, 2015 - 2026 (USD Million)
8.6.3    Market size, by therapeutic area, 2015 - 2026 (USD Million)
8.6.4    Market size, by patient, 2015 - 2026 (USD Million)
8.6.5    Market size, by route of administration, 2015 - 2026 (USD Million)
8.6.6    South Africa
8.6.6.1    Market size, by drug type, 2015 - 2026 (USD Million)
8.6.6.2    Market size, by therapeutic area, 2015 - 2026 (USD Million)
8.6.6.3    Market size, by patient, 2015 - 2026 (USD Million)
8.6.6.4    Market size, by route of administration, 2015 - 2026 (USD Million)
8.6.7    Saudi Arabia
8.6.7.1    Market size, by drug type, 2015 - 2026 (USD Million)
8.6.7.2    Market size, by therapeutic area, 2015 - 2026 (USD Million)
8.6.7.3    Market size, by patient, 2015 - 2026 (USD Million)
8.6.7.4    Market size, by route of administration, 2015 - 2026 (USD Million)
8.6.8    UAE
8.6.8.1    Market size, by drug type, 2015 - 2026 (USD Million)
8.6.8.2    Market size, by therapeutic area, 2015 - 2026 (USD Million)
8.6.8.3    Market size, by patient, 2015 - 2026 (USD Million)
8.6.8.4    Market size, by route of administration, 2015 - 2026 (USD Million)
Chapter 9   Company Profiles 
9.1    Competitive dashboard, 2019
9.2    AbbVie Inc
9.2.1    Business overview
9.2.2    Financial data
9.2.3    Product landscape
9.2.4    Strategic outlook
9.2.5    SWOT analysis
9.3    Actelion Pharmaceuticals Ltd
9.3.1    Business overview
9.3.2    Financial data
9.3.3    Product landscape
9.3.4    Strategic outlook
9.3.5    SWOT analysis
9.4    Alexion Pharmaceuticals, Inc
9.4.1    Business overview
9.4.2    Financial data
9.4.3    Product landscape
9.4.4    Strategic outlook
9.4.5    SWOT analysis
9.5    Amgen Inc
9.5.1    Business overview
9.5.2    Financial data
9.5.3    Product landscape
9.5.4    Strategic outlook
9.5.5    SWOT analysis
9.6    Baxter
9.6.1    Business overview
9.6.2    Financial data
9.6.3    Product landscape
9.6.4    Strategic outlook
9.6.5    SWOT analysis
9.7    Bayer AG
9.7.1    Business overview
9.7.2    Financial data
9.7.3    Product landscape
9.7.4    Strategic outlook
9.7.5    SWOT analysis
9.8    Biogen
9.8.1    Business overview
9.8.2    Financial data
9.8.3    Product landscape
9.8.4    Strategic outlook
9.8.5    SWOT analysis
9.9    Bristol-Myers Squibb
9.9.1    Business overview
9.9.2    Financial data
9.9.3    Product landscape
9.9.4    Strategic outlook
9.9.5    SWOT analysis
9.10    Celgene Corporation
9.10.1    Business overview
9.10.2    Financial data
9.10.3    Product landscape
9.10.4    Strategic outlook
9.10.5    SWOT analysis
9.11    Eli Lilly and Company
9.11.1    Business overview
9.11.2    Financial data
9.11.3    Product landscape
9.11.4    Strategic outlook
9.11.5    SWOT analysis
9.12    Hoffman-La-Roche
9.12.1    Business overview
9.12.2    Financial data
9.12.3    Product landscape
9.12.4    Strategic outlook
9.12.5    SWOT analysis
9.13    GlaxoSmithKline plc
9.13.1    Business overview
9.13.2    Financial data
9.13.3    Product landscape
9.13.4    Strategic outlook
9.13.5    SWOT analysis
9.14    Johnson & Johnson
9.14.1    Business overview
9.14.2    Financial data
9.14.3    Product landscape
9.14.4    Strategic outlook
9.14.5    SWOT analysis
9.15    Merck Sharp & Dohme
9.15.1    Business overview
9.15.2    Financial data
9.15.3    Product landscape
9.15.4    Strategic outlook
9.15.5    SWOT analysis
9.16    Novartis AG
9.16.1    Business overview
9.16.2    Financial data
9.16.3    Product landscape
9.16.4    Strategic outlook
9.16.5    SWOT analysis
9.17    Pfizer Inc.
9.17.1    Business overview
9.17.2    Financial data
9.17.3    Product landscape
9.17.4    Strategic outlook
9.17.5    SWOT analysis
9.18    Pharmacyclics LLC
9.18.1    Business overview
9.18.2    Financial data
9.18.3    Product landscape
9.18.4    Strategic outlook
9.18.5    SWOT analysis
9.19    Sanofi
9.19.1    Business overview
9.19.2    Financial data
9.19.3    Product landscape
9.19.4    Strategic outlook
9.19.5    SWOT analysis
9.20    Takeda Pharmaceutical Company Limited
9.20.1    Business overview
9.20.2    Financial data
9.20.3    Product landscape
9.20.4    Strategic outlook
9.20.5    SWOT analysis
9.21    Vertex Pharmaceuticals Incorporated
9.21.1    Business overview
9.21.2    Financial data
9.21.3    Product landscape
9.21.4    Strategic outlook
9.21.5    SWOT analysis

Data Tables TABLE 1. Global rare disease treatment market, 2015 - 2019 (USD Million) TABLE 2. Global rare disease treatment market, 2020 - 2026 (USD Million) TABLE 3. Global rare disease treatment market, by drug type, 2015 - 2019 (USD Million) TABLE 4. Global rare disease treatment market, by drug type, 2020 - 2026 (USD Million) TABLE 5. Global rare disease treatment market, by therapeutic area, 2015 - 2019 (USD Million) TABLE 6. Global rare disease treatment market, by therapeutic area, 2020 - 2026 (USD Million) TABLE 7. Global rare disease treatment market, by patient, 2015 - 2019 (USD Million) TABLE 8. Global rare disease treatment market, by patient, 2020 - 2026 (USD Million) TABLE 9. Global rare disease treatment market, by route of administration, 2015 - 2019 (USD Million) TABLE 10. Global rare disease treatment market, by route of administration, 2020 - 2026 (USD Million) TABLE 11. Global rare disease treatment market, by region, 2015 - 2019 (USD Million) TABLE 12. Global rare disease treatment market, by region, 2020 - 2026 (USD Million) TABLE 13. Industry impact forces TABLE 14. Biologics market size, by region, 2015 - 2019 (USD Million) TABLE 15. Biologics market size, by region, 2020 - 2026 (USD Million) TABLE 16. Non-biologics market size, by region, 2015 - 2019 (USD Million) TABLE 17. Non-biologics market size, by region, 2020 - 2026 (USD Million) TABLE 18. Cancer market size, by region, 2015 - 2019 (USD Million) TABLE 19. Cancer market size, by region, 2020 - 2026 (USD Million) TABLE 20. Blood-related disorders market size, by region, 2015 - 2019 (USD Million) TABLE 21. Blood-related disorders market size, by region, 2020 - 2026 (USD Million) TABLE 22. Central nervous system market size, by region, 2015 - 2019 (USD Million) TABLE 23. Central nervous system market size, by region, 2020 - 2026 (USD Million) TABLE 24. Respiratory disorders market size, by region, 2015 - 2019 (USD Million) TABLE 25. Respiratory disorders market size, by region, 2020 - 2026 (USD Million) TABLE 26. Musculoskeletal disorders market size, by region, 2015 - 2019 (USD Million) TABLE 27. Musculoskeletal disorders market size, by region, 2020 - 2026 (USD Million) TABLE 28. Cardiovascular disorders market size, by region, 2015 - 2019 (USD Million) TABLE 29. Cardiovascular disorders market size, by region, 2020 - 2026 (USD Million) TABLE 30. Adult market size, by region, 2015 - 2019 (USD Million) TABLE 31. Adult market size, by region, 2020 - 2026 (USD Million) TABLE 32. Pediatric market size, by region, 2015 - 2019 (USD Million) TABLE 33. Pediatric market size, by region, 2020 - 2026 (USD Million) TABLE 34. Oral market size, by region, 2015 - 2019 (USD Million) TABLE 35. Oral market size, by region, 2020 - 2026 (USD Million) TABLE 36. Injectable market size, by region, 2015 - 2019 (USD Million) TABLE 37. Injectable market size, by region, 2020 - 2026 (USD Million) TABLE 38. North America rare disease treatment market size, by country, 2015 - 2019 (USD Million) TABLE 39. North America rare disease treatment market size, by country, 2020 - 2026 (USD Million) TABLE 40. North America rare disease treatment market size, by drug type, 2015 - 2019 (USD Million) TABLE 41. North America rare disease treatment market size, by drug type, 2020 - 2026 (USD Million) TABLE 42. North America rare disease treatment market size, by therapeutic area, 2015 - 2019 (USD Million) TABLE 43. North America rare disease treatment market size, by therapeutic area, 2020 - 2026 (USD Million) TABLE 44. North America rare disease treatment market size, by patient, 2015 - 2019 (USD Million) TABLE 45. North America rare disease treatment market size, by patient, 2020 - 2026 (USD Million) TABLE 46. North America rare disease treatment market size, by route of administration, 2015 - 2019 (USD Million) TABLE 47. North America rare disease treatment market size, by route of administration, 2020 - 2026 (USD Million) TABLE 48. U.S. rare disease treatment market size, by drug type, 2015 - 2019 (USD Million) TABLE 49. U.S. rare disease treatment market size, by drug type, 2020 - 2026 (USD Million) TABLE 50. U.S. rare disease treatment market size, by therapeutic area, 2015 - 2019 (USD Million) TABLE 51. U.S. rare disease treatment market size, by therapeutic area, 2020 - 2026 (USD Million) TABLE 52. U.S. rare disease treatment market size, by patient, 2015 - 2019 (USD Million) TABLE 53. U.S. rare disease treatment market size, by patient, 2020 - 2026 (USD Million) TABLE 54. U.S. rare disease treatment market size, by route of administration, 2015 - 2019 (USD Million) TABLE 55. U.S. rare disease treatment market size, by route of administration, 2020 - 2026 (USD Million) TABLE 56. Canada rare disease treatment market size, by drug type, 2015 - 2019 (USD Million) TABLE 57. Canada rare disease treatment market size, by drug type, 2020 - 2026 (USD Million) TABLE 58. Canada rare disease treatment market size, by therapeutic area, 2015 - 2019 (USD Million) TABLE 59. Canada rare disease treatment market size, by therapeutic area, 2020 - 2026 (USD Million) TABLE 60. Canada rare disease treatment market size, by patient, 2015 - 2019 (USD Million) TABLE 61. Canada rare disease treatment market size, by patient, 2020 - 2026 (USD Million) TABLE 62. Canada rare disease treatment market size, by route of administration, 2015 - 2019 (USD Million) TABLE 63. Canada rare disease treatment market size, by route of administration, 2020 - 2026 (USD Million) TABLE 64. Europe rare disease treatment market size, by country, 2015 - 2019 (USD Million) TABLE 65. Europe rare disease treatment market size, by country, 2020 - 2026 (USD Million) TABLE 66. Europe rare disease treatment market size, by drug type, 2015 - 2019 (USD Million) TABLE 67. Europe rare disease treatment market size, by drug type, 2020 - 2026 (USD Million) TABLE 68. Europe rare disease treatment market size, by therapeutic area, 2015 - 2019 (USD Million) TABLE 69. Europe rare disease treatment market size, by therapeutic area, 2020 - 2026 (USD Million) TABLE 70. Europe rare disease treatment market size, by patient, 2015 - 2019 (USD Million) TABLE 71. Europe rare disease treatment market size, by patient, 2020 - 2026 (USD Million) TABLE 72. Europe rare disease treatment market size, by route of administration, 2015 - 2019 (USD Million) TABLE 73. Europe rare disease treatment market size, by route of administration, 2020 - 2026 (USD Million) TABLE 74. Germany rare disease treatment market size, by drug type, 2015 - 2019 (USD Million) TABLE 75. Germany rare disease treatment market size, by drug type, 2020 - 2026 (USD Million) TABLE 76. Germany rare disease treatment market size, by therapeutic area, 2015 - 2019 (USD Million) TABLE 77. Germany rare disease treatment market size, by therapeutic area, 2020 - 2026 (USD Million) TABLE 78. Germany rare disease treatment market size, by patient, 2015 - 2019 (USD Million) TABLE 79. Germany rare disease treatment market size, by patient, 2020 - 2026 (USD Million) TABLE 80. Germany rare disease treatment market size, by route of administration, 2015 - 2019 (USD Million) TABLE 81. Germany rare disease treatment market size, by route of administration, 2020 - 2026 (USD Million) TABLE 82. UK rare disease treatment market size, by drug type, 2015 - 2019 (USD Million) TABLE 83. UK rare disease treatment market size, by drug type, 2020 - 2026 (USD Million) TABLE 84. UK rare disease treatment market size, by therapeutic area, 2015 - 2019 (USD Million) TABLE 85. UK rare disease treatment market size, by therapeutic area, 2020 - 2026 (USD Million) TABLE 86. UK rare disease treatment market size, by patient, 2015 - 2019 (USD Million) TABLE 87. UK rare disease treatment market size, by patient, 2020 - 2026 (USD Million) TABLE 88. UK rare disease treatment market size, by route of administration, 2015 - 2019 (USD Million) TABLE 89. UK rare disease treatment market size, by route of administration, 2020 - 2026 (USD Million) TABLE 90. France rare disease treatment market size, by drug type, 2015 - 2019 (USD Million) TABLE 91. France rare disease treatment market size, by drug type, 2020 - 2026 (USD Million) TABLE 92. France rare disease treatment market size, by therapeutic area, 2015 - 2019 (USD Million) TABLE 93. France rare disease treatment market size, by therapeutic area, 2020 - 2026 (USD Million) TABLE 94. France rare disease treatment market size, by patient, 2015 - 2019 (USD Million) TABLE 95. France rare disease treatment market size, by patient, 2020 - 2026 (USD Million) TABLE 96. France rare disease treatment market size, by route of administration, 2015 - 2019 (USD Million) TABLE 97. France rare disease treatment market size, by route of administration, 2020 - 2026 (USD Million) TABLE 98. Spain rare disease treatment market size, by drug type, 2015 - 2019 (USD Million) TABLE 99. Spain rare disease treatment market size, by drug type, 2020 - 2026 (USD Million) TABLE 100. Spain rare disease treatment market size, by therapeutic area, 2015 - 2019 (USD Million) TABLE 101. Spain rare disease treatment market size, by therapeutic area, 2020 - 2026 (USD Million) TABLE 102. Spain rare disease treatment market size, by patient, 2015 - 2019 (USD Million) TABLE 103. Spain rare disease treatment market size, by patient, 2020 - 2026 (USD Million) TABLE 104. Spain rare disease treatment market size, by route of administration, 2015 - 2019 (USD Million) TABLE 105. Spain rare disease treatment market size, by route of administration, 2020 - 2026 (USD Million) TABLE 106. Italy rare disease treatment market size, by drug type, 2015 - 2019 (USD Million) TABLE 107. Italy rare disease treatment market size, by drug type, 2020 - 2026 (USD Million) TABLE 108. Italy rare disease treatment market size, by therapeutic area, 2015 - 2019 (USD Million) TABLE 109. Italy rare disease treatment market size, by therapeutic area, 2020 - 2026 (USD Million) TABLE 110. Italy rare disease treatment market size, by patient, 2015 - 2019 (USD Million) TABLE 111. Italy rare disease treatment market size, by patient, 2020 - 2026 (USD Million) TABLE 112. Italy rare disease treatment market size, by route of administration, 2015 - 2019 (USD Million) TABLE 113. Italy rare disease treatment market size, by route of administration, 2020 - 2026 (USD Million) TABLE 114. Asia Pacific rare disease treatment market size, by country, 2015 - 2019 (USD Million) TABLE 115. Asia Pacific rare disease treatment market size, by country, 2020 - 2026 (USD Million) TABLE 116. Asia Pacific rare disease treatment market size, by drug type, 2015 - 2019 (USD Million) TABLE 117. Asia Pacific rare disease treatment market size, by drug type, 2020 - 2026 (USD Million) TABLE 118. Asia Pacific rare disease treatment market size, by therapeutic area, 2015 - 2019 (USD Million) TABLE 119. Asia Pacific rare disease treatment market size, by therapeutic area, 2020 - 2026 (USD Million) TABLE 120. Asia Pacific rare disease treatment market size, by patient, 2015 - 2019 (USD Million) TABLE 121. Asia Pacific rare disease treatment market size, by patient, 2020 - 2026 (USD Million) TABLE 122. Asia Pacific rare disease treatment market size, by route of administration, 2015 - 2019 (USD Million) TABLE 123. Asia Pacific rare disease treatment market size, by route of administration, 2020 - 2026 (USD Million) TABLE 124. China rare disease treatment market size, by drug type, 2015 - 2019 (USD Million) TABLE 125. China rare disease treatment market size, by drug type, 2020 - 2026 (USD Million) TABLE 126. China rare disease treatment market size, by therapeutic area, 2015 - 2019 (USD Million) TABLE 127. China rare disease treatment market size, by therapeutic area, 2020 - 2026 (USD Million) TABLE 128. China rare disease treatment market size, by patient, 2015 - 2019 (USD Million) TABLE 129. China rare disease treatment market size, by patient, 2020 - 2026 (USD Million) TABLE 130. China rare disease treatment market size, by route of administration, 2015 - 2019 (USD Million) TABLE 131. China rare disease treatment market size, by route of administration, 2020 - 2026 (USD Million) TABLE 132. Japan rare disease treatment market size, by drug type, 2015 - 2019 (USD Million) TABLE 133. Japan rare disease treatment market size, by drug type, 2020 - 2026 (USD Million) TABLE 134. Japan rare disease treatment market size, by therapeutic area, 2015 - 2019 (USD Million) TABLE 135. Japan rare disease treatment market size, by therapeutic area, 2020 - 2026 (USD Million) TABLE 136. Japan rare disease treatment market size, by patient, 2015 - 2019 (USD Million) TABLE 137. Japan rare disease treatment market size, by patient, 2020 - 2026 (USD Million) TABLE 138. Japan rare disease treatment market size, by route of administration, 2015 - 2019 (USD Million) TABLE 139. Japan rare disease treatment market size, by route of administration, 2020 - 2026 (USD Million) TABLE 140. India rare disease treatment market size, by drug type, 2015 - 2019 (USD Million) TABLE 141. India rare disease treatment market size, by drug type, 2020 - 2026 (USD Million) TABLE 142. India rare disease treatment market size, by therapeutic area, 2015 - 2019 (USD Million) TABLE 143. India rare disease treatment market size, by therapeutic area, 2020 - 2026 (USD Million) TABLE 144. India rare disease treatment market size, by patient, 2015 - 2019 (USD Million) TABLE 145. India rare disease treatment market size, by patient, 2020 - 2026 (USD Million) TABLE 146. India rare disease treatment market size, by route of administration, 2015 - 2019 (USD Million) TABLE 147. India rare disease treatment market size, by route of administration, 2020 - 2026 (USD Million) TABLE 148. Australia rare disease treatment market size, by drug type, 2015 - 2019 (USD Million) TABLE 149. Australia rare disease treatment market size, by drug type, 2020 - 2026 (USD Million) TABLE 150. Australia rare disease treatment market size, by therapeutic area, 2015 - 2019 (USD Million) TABLE 151. Australia rare disease treatment market size, by therapeutic area, 2020 - 2026 (USD Million) TABLE 152. Australia rare disease treatment market size, by patient, 2015 - 2019 (USD Million) TABLE 153. Australia rare disease treatment market size, by patient, 2020 - 2026 (USD Million) TABLE 154. Australia rare disease treatment market size, by route of administration, 2015 - 2019 (USD Million) TABLE 155. Australia rare disease treatment market size, by route of administration, 2020 - 2026 (USD Million) TABLE 156. South Korea rare disease treatment market size, by drug type, 2015 - 2019 (USD Million) TABLE 157. South Korea rare disease treatment market size, by drug type, 2020 - 2026 (USD Million) TABLE 158. South Korea rare disease treatment market size, by therapeutic area, 2015 - 2019 (USD Million) TABLE 159. South Korea rare disease treatment market size, by therapeutic area, 2020 - 2026 (USD Million) TABLE 160. South Korea rare disease treatment market size, by patient, 2015 - 2019 (USD Million) TABLE 161. South Korea rare disease treatment market size, by patient, 2020 - 2026 (USD Million) TABLE 162. South Korea rare disease treatment market size, by route of administration, 2015 - 2019 (USD Million) TABLE 163. South Korea rare disease treatment market size, by route of administration, 2020 - 2026 (USD Million) TABLE 164. Latin America rare disease treatment market size, by country, 2015 - 2019 (USD Million) TABLE 165. Latin America rare disease treatment market size, by country, 2020 - 2026 (USD Million) TABLE 166. Latin America rare disease treatment market size, by drug type, 2015 - 2019 (USD Million) TABLE 167. Latin America rare disease treatment market size, by drug type, 2020 - 2026 (USD Million) TABLE 168. Latin America rare disease treatment market size, by therapeutic area, 2015 - 2019 (USD Million) TABLE 169. Latin America rare disease treatment market size, by therapeutic area, 2020 - 2026 (USD Million) TABLE 170. Latin America rare disease treatment market size, by patient, 2015 - 2019 (USD Million) TABLE 171. Latin America rare disease treatment market size, by patient, 2020 - 2026 (USD Million) TABLE 172. Latin America rare disease treatment market size, by route of administration, 2015 - 2019 (USD Million) TABLE 173. Latin America rare disease treatment market size, by route of administration, 2020 - 2026 (USD Million) TABLE 174. Brazil rare disease treatment market size, by drug type, 2015 - 2019 (USD Million) TABLE 175. Brazil rare disease treatment market size, by drug type, 2020 - 2026 (USD Million) TABLE 176. Brazil rare disease treatment market size, by therapeutic area, 2015 - 2019 (USD Million) TABLE 177. Brazil rare disease treatment market size, by therapeutic area, 2020 - 2026 (USD Million) TABLE 178. Brazil rare disease treatment market size, by patient, 2015 - 2019 (USD Million) TABLE 179. Brazil rare disease treatment market size, by patient, 2020 - 2026 (USD Million) TABLE 180. Brazil rare disease treatment market size, by route of administration, 2015 - 2019 (USD Million) TABLE 181. Brazil rare disease treatment market size, by route of administration, 2020 - 2026 (USD Million) TABLE 182. Mexico rare disease treatment market size, by drug type, 2015 - 2019 (USD Million) TABLE 183. Mexico rare disease treatment market size, by drug type, 2020 - 2026 (USD Million) TABLE 184. Mexico rare disease treatment market size, by therapeutic area, 2015 - 2019 (USD Million) TABLE 185. Mexico rare disease treatment market size, by therapeutic area, 2020 - 2026 (USD Million) TABLE 186. Mexico rare disease treatment market size, by patient, 2015 - 2019 (USD Million) TABLE 187. Mexico rare disease treatment market size, by patient, 2020 - 2026 (USD Million) TABLE 188. Mexico rare disease treatment market size, by route of administration, 2015 - 2019 (USD Million) TABLE 189. Mexico rare disease treatment market size, by route of administration, 2020 - 2026 (USD Million) TABLE 190. Argentina rare disease treatment market size, by drug type, 2015 - 2019 (USD Million) TABLE 191. Argentina rare disease treatment market size, by drug type, 2020 - 2026 (USD Million) TABLE 192. Argentina rare disease treatment market size, by therapeutic area, 2015 - 2019 (USD Million) TABLE 193. Argentina rare disease treatment market size, by therapeutic area, 2020 - 2026 (USD Million) TABLE 194. Argentina rare disease treatment market size, by patient, 2015 - 2019 (USD Million) TABLE 195. Argentina rare disease treatment market size, by patient, 2020 - 2026 (USD Million) TABLE 196. Argentina rare disease treatment market size, by route of administration, 2015 - 2019 (USD Million) TABLE 197. Argentina rare disease treatment market size, by route of administration, 2020 - 2026 (USD Million) TABLE 198. Middle East and Africa rare disease treatment market size, by country, 2015 - 2019 (USD Million) TABLE 199. Middle East and Africa rare disease treatment market size, by country, 2020 - 2026 (USD Million) TABLE 200. Middle East and Africa rare disease treatment market size, by drug type, 2015 - 2019 (USD Million) TABLE 201. Middle East and Africa rare disease treatment market size, by drug type, 2020 - 2026 (USD Million) TABLE 202. Middle East and Africa rare disease treatment market size, by therapeutic area, 2015 - 2019 (USD Million) TABLE 203. Middle East and Africa rare disease treatment market size, by therapeutic area, 2020 - 2026 (USD Million) TABLE 204. Middle East and Africa rare disease treatment market size, by patient, 2015 - 2019 (USD Million) TABLE 205. Middle East and Africa rare disease treatment market size, by patient, 2020 - 2026 (USD Million) TABLE 206. Middle East and Africa rare disease treatment market size, by route of administration, 2015 - 2019 (USD Million) TABLE 207. Middle East and Africa rare disease treatment market size, by route of administration, 2020 - 2026 (USD Million) TABLE 208. South Africa rare disease treatment market size, by drug type, 2015 - 2019 (USD Million) TABLE 209. South Africa rare disease treatment market size, by drug type, 2020 - 2026 (USD Million) TABLE 210. South Africa rare disease treatment market size, by therapeutic area, 2015 - 2019 (USD Million) TABLE 211. South Africa rare disease treatment market size, by therapeutic area, 2020 - 2026 (USD Million) TABLE 212. South Africa rare disease treatment market size, by patient, 2015 - 2019 (USD Million) TABLE 213. South Africa rare disease treatment market size, by patient, 2020 - 2026 (USD Million) TABLE 214. South Africa rare disease treatment market size, by route of administration, 2015 - 2019 (USD Million) TABLE 215. South Africa rare disease treatment market size, by route of administration, 2020 - 2026 (USD Million) TABLE 216. Saudi Arabia rare disease treatment market size, by drug type, 2015 - 2019 (USD Million) TABLE 217. Saudi Arabia rare disease treatment market size, by drug type, 2020 - 2026 (USD Million) TABLE 218. Saudi Arabia rare disease treatment market size, by therapeutic area, 2015 - 2019 (USD Million) TABLE 219. Saudi Arabia rare disease treatment market size, by therapeutic area, 2020 - 2026 (USD Million) TABLE 220. Saudi Arabia rare disease treatment market size, by patient, 2015 - 2019 (USD Million) TABLE 221. Saudi Arabia rare disease treatment market size, by patient, 2020 - 2026 (USD Million) TABLE 222. Saudi Arabia rare disease treatment market size, by route of administration, 2015 - 2019 (USD Million) TABLE 223. Saudi Arabia rare disease treatment market size, by route of administration, 2020 - 2026 (USD Million) TABLE 224. UAE rare disease treatment market size, by drug type, 2015 - 2019 (USD Million) TABLE 225. UAE rare disease treatment market size, by drug type, 2020 - 2026 (USD Million) TABLE 226. UAE rare disease treatment market size, by therapeutic area, 2015 - 2019 (USD Million) TABLE 227. UAE rare disease treatment market size, by therapeutic area, 2020 - 2026 (USD Million) TABLE 228. UAE rare disease treatment market size, by patient, 2015 - 2019 (USD Million) TABLE 229. UAE rare disease treatment market size, by patient, 2020 - 2026 (USD Million) TABLE 230. UAE rare disease treatment market size, by route of administration, 2015 - 2019 (USD Million) TABLE 231. UAE rare disease treatment market size, by route of administration, 2020 - 2026 (USD Million) Charts & Figures FIG. 1 Top-down approach FIG. 2 Data validation FIG. 3 Rare disease treatment industry 360 degree synopsis, 2015 - 2026 FIG. 4 Industry segmentation FIG. 5 Global rare disease treatment market, 2015 - 2026 (USD Million) FIG. 6 Growth potential analysis, by drug type FIG. 7 Growth potential analysis, by therapeutic area FIG. 8 Growth potential analysis, by patient FIG. 9 Growth potential analysis, by route of administration FIG. 10 Porter's analysis FIG. 11 Competitive matrix analysis, 2019 FIG. 12 PESTEL analysis FIG. 13 Key segment trends, by drug type FIG. 14 Key segment trends, by therapeutic area FIG. 15 Key segment trends, by patient FIG. 16 Key segment trends, by route of administration FIG. 17 Key regional trends FIG. 18 Competitive dashboard, 2019

Name*
Email ID*
Company*
Phone (With Country Code)*
What is/are your question(s)?:
Publisher: Global Market Insights, Inc.
Chat with us